|
|
Cat. No |
Model |
Description |
Unit |
Price (VATº°µµ) |
³³±â |
Àç°í |
DataSheet |
ÁÖ¹®/°ßÀû |
LCA-25-394604 |
GTX72624(R) |
Actin, Muscle (HHF35) Antibody// |
1/EA |
|
|
|
|
¹®ÀÇ |
|
|
|
|
|
|
Subject
|
Actin, Muscle (HHF35) Antibody |
Description
|
/ |
Clonality
|
Mono |
Company
|
GeneTex |
Application
|
IHC-Fr, IHC-P |
Conjugation
|
|
Immunogen
|
|
Contents
|
Catalog Number | GTX72624 | Product Name | Actin, Muscle (HHF35) Antibody | Product Description | Mouse Monoclonal to Actin Muscle | Background | Recognizes a 42 kD protein alpha and gamma actin from skeletal, cardiac and smooth muscle cells but is non-reactive with beta isomers.This antibody also recognizes myocardial, skeletal and smooth muscle cells, as well as, myoepithelial cells, pericytes of small vessels. All other non-muscle cells are negative. | Clonality | Monoclonal | Clone No | HHF35 | Host | Mouse | Isotype | IgG1 | Immunogen | BALB/C mice were immunized with SDS extracted protein fraction of Human Myocardium. | Antigen Species | Human | Tested Applications | IHC (Frozen sections), IHC (Formalin-fixed paraffin-embedded sections). The usefulness of this product in other applications has not been determined. | Application Note | Immunohistochemistry (Paraffin/Frozen). Prolonged fixation in buffered formalin can destroy the epitope. The antibody may be used at a dilution of 1:10 to 1:20 with AutoProbe III (GTX28620). It is recommended that this product be used on frozen tissue sections or specimens. The optimal conditions should be determined by the individual laboratory. Dilute according to the particular application being used. In general, the 0.05M Borate pH 8.0 containing 0.15M Sodium Chloride, 0.05% Sodium Azide, is a good diluent to use with most antibodies. | Target | Actin Muscle | Cellular Localization | Cytoplasmic | Form Supplied | Dehydrated | Storage Buffer | 20mM borate, 20mg/ml glucose, 0.05% green dye (food) and 0.05% sodium azdie. | Storage Instruction | Keep as concentrated solution, aliquot and store at 4¡ÆC. Do not freeze. | |
|
|
|
|